16.03.2020 Geratherm Medical AG  DE0005495626

DGAP-Adhoc: Geratherm Medical AG: Increase of production due to Corona Virus


DGAP-Ad-hoc: Geratherm Medical AG / Key word(s): Miscellaneous
Geratherm Medical AG: Increase of production due to Corona Virus

16-March-2020 / 11:57 CET/CEST
Disclosure of an inside information acc. to Article 17 MAR of the Regulation (EU) No 596/2014, transmitted by DGAP - a service of EQS Group AG.
The issuer is solely responsible for the content of this announcement.

Public disclosure of inside information pursuant to Art. 17 MAR,
transmitted by DGAP - a service of EQS Group AG

Key word: Geratherm Medical, Increase of production due to Corona Virus

Geratherm Medical March 16th, 2020: Geratherm Medical manufactures medical devices such as clinical thermometer and devices for lung function tests. The current demand exceeds the supply by far.

The production of clinical thermometers will be increased gradually from 2-shift to 3-shift-system. The hitherto existing shift on Saturday will be kept. This arrangement will be kept until the mid of 2020, at least. Geratherm Medical is the only manufacturer of analogue clinical thermometer in Europe.

To secure the production of needed medical devices, the Thuringian Ministry announced today that Geratherm had been granted the special status "critical infrastructure". This includes, among others, daycare for the children of the employees of the company.

Geratherm Medical AG
Firmensitz: Fahrenheitstraße 1, 99331 Geratal
Registergericht: Amtsgericht Jena, HRB 111272
Vorstand: Dr. Gert Frank
Aufsichtsratsvorsitzender: Dipl.-Kfm. Rudolf Bröcker
Tel. 036205/98 0; Fax: 036205/98 115
E-Mail: [email protected]

Short company profil:
Geratherm Medical is an internationally operating medical products enterprise with the business areas Healthcare Diagnostic, Medical Warming Systems, Cardio/Stroke and Respiratory. Our company's roots are in temperature measurement in the medical sphere. In this business area we offer a broad spectrum of products, most of which have unique selling points. We supply our customers/patients with high-quality products ranging from thermometers to complex warming systems for use in the operating theatre and by emergency rescue services and MR Diagnostic Incubator Systems for premature babies and newborns. In the Cardio business area we concentrate on the development of products for the detection of atrial fibrillation as a measure to prevent strokes. The Respiratory segment develops and markets products for the assessment of pulmonary function. In all mainly business areas, Geratherm has patent-protected basic technologies at its disposal. We regard ourselves as a research-based medical products company with a clear focus on medical diagnostic devices that generate vital data. Geratherm shares have been listed in the Prime Standard segment of the Frankfurt Stock Exchange since the year 2000. Geratherm Medical continues to be represented in the German Entrepreneurial Index and in the German Healthcare Index.

Dr. Gert Frank

16-March-2020 CET/CEST The DGAP Distribution Services include Regulatory Announcements, Financial/Corporate News and Press Releases.
Archive at www.dgap.de

Language: English
Company: Geratherm Medical AG
Fahrenheitstraße 1
98716 Geschwenda
Phone: +49 (0)36205 98-0
Fax: +49 (0)36205 98-1 15
E-mail: [email protected]
Internet: www.geratherm.com
ISIN: DE0005495626
WKN: 549562
Listed: Regulated Market in Frankfurt (Prime Standard); Regulated Unofficial Market in Berlin, Dusseldorf, Hamburg, Munich, Stuttgart, Tradegate Exchange
EQS News ID: 998011

End of Announcement DGAP News Service

998011  16-March-2020 CET/CEST


Die wichtigsten Finanzdaten auf einen Blick
  2015 2016 2017 2018 2019 2020 2021e
Umsatzerlöse1 21,59 21,41 21,03 21,52 19,85 27,47 28,90
EBITDA1,2 3,42 3,71 1,77 2,80 2,35 4,35 5,00
EBITDA-Marge3 15,84 17,33 8,42 13,01 11,84 15,84 17,30
EBIT1,4 2,53 2,54 0,63 1,99 1,05 3,04 3,60
EBIT-Marge5 11,72 11,86 3,00 9,25 5,29 11,07 12,46
Jahresüberschuss1 2,39 2,25 0,22 0,83 0,29 1,90 2,50
Netto-Marge6 11,07 10,51 1,05 3,86 1,46 6,92 8,65
Cashflow1,7 3,77 0,79 2,47 1,35 1,54 3,92 4,55
Ergebnis je Aktie8 0,55 0,45 0,14 0,23 0,11 0,41 0,48
Dividende8 0,50 0,50 0,47 0,40 0,25 0,40 0,42
Quelle: boersengefluester.de und Firmenangaben

  Geschäftsbericht 2020 - Kostenfrei herunterladen.  
1 in Mio. Euro; 2 EBITDA = Ergebnis vor Zinsen, Steuern und Abschreibungen; 3 EBITDA in Relation zum Umsatz; 4 EBIT = Ergebnis vor Zinsen und Steuern; 5 EBIT in Relation zum Umsatz; 6 Jahresüberschuss (-fehlbetrag) in Relation zum Umsatz; 7 Cashflow aus der gewöhnlichen Geschäftstätigkeit; 8 in Euro; Quelle: boersengefluester.de

Wirtschaftsprüfer: BDO

Geratherm Medical
WKN Kurs in € Einschätzung Börsenwert in Mio. €
549562 9,040 Kaufen 44,75
KGV 2022e KGV 10Y-Ø BGFL-Ratio Shiller-KGV
13,49 25,06 0,54 27,15
2,49 11,43 1,63 10,09
Dividende '19 in € Dividende '20e in € Div.-Rendite '20e
in %
0,25 0,40 4,42 11.06.2021
Q1-Zahlen Q2-Zahlen Q3-Zahlen Bilanz-PK
20.05.2021 25.08.2021 24.11.2021 28.04.2021
Abstand 60Tage-Linie Abstand 200Tage-Linie Performance YtD Performance 52 Wochen
-7,99% -18,05% -17,06% -18,56%
Weitere Ad-hoc und Unternehmensrelevante Mitteilungen zu Geratherm Medical AG  ISIN: DE0005495626 können Sie bei DGAP abrufen

Medtech , 549562 , GME , XETR:GME